Updates from the 48th Annual San Antonio Breast Cancer Symposium

from All CancerCare Connect Education Workshops

- Novel Therapy for Adjuvant Hormone Receptor Positive Breast Cancer - Antibody Drug Conjugates in First Line Metastatic Hormone Receptor Positive Breast Cancer - Tailoring First Line Therapy in Metastatic HER2 Positive Breast Cancer - Integration & Sequencing of Novel Oral Selective Estrogen Receptor Degraders (SERDs) in Metastatic Hormone Receptor Positive Breast Cancer - Deescalating Therapy in Low-Risk Ductal Carcinoma In Situ (DCIS) - Questions for Our Panel of Experts

Episode metadata supplied by the publisher feed · Published Dec 17, 2025

Embed this episode

Attribution link and audio player

Ready to play

Updates from the 48th Annual San Antonio Breast Cancer Symposium

0:00 53:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of All CancerCare Connect Education Workshops?

This episode is 53 minutes long.

When was this All CancerCare Connect Education Workshops episode published?

This episode was published on December 17, 2025.

Can I download this All CancerCare Connect Education Workshops episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!